SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-19-003072
Filing Date
2019-05-07
Accepted
2019-05-07 16:47:14
Documents
63
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q f10q_050719p.htm 10-Q 493504
2 EXHIBIT 10.1 exh_101.htm EX-10.1 174174
3 EXHIBIT 10.2 exh_102.htm EX-10.2 70387
4 EXHIBIT 31.1 exh_311.htm EX-31.1 9916
5 EXHIBIT 31.2 exh_312.htm EX-31.2 10014
6 EXHIBIT 32.1 exh_321.htm EX-32.1 3424
7 EXHIBIT 32.2 exh_322.htm EX-32.2 3414
14 GRAPHIC logo.jpg GRAPHIC 112354
  Complete submission text file 0001171843-19-003072.txt   3149430

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE FILE apto-20190331.xml EX-101.INS 420152
9 XBRL SCHEMA FILE apto-20190331.xsd EX-101.SCH 40577
10 XBRL CALCULATION FILE apto-20190331_cal.xml EX-101.CAL 28704
11 XBRL DEFINITION FILE apto-20190331_def.xml EX-101.DEF 244665
12 XBRL LABEL FILE apto-20190331_lab.xml EX-101.LAB 208570
13 XBRL PRESENTATION FILE apto-20190331_pre.xml EX-101.PRE 269512
Mailing Address 251 CONSUMERS ROAD SUITE 1105 TORONTO A6 M2J 4R3
Business Address 251 CONSUMERS ROAD SUITE 1105 TORONTO A6 M2J 4R3 647-479-9828
Aptose Biosciences Inc. (Filer) CIK: 0000882361 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32001 | Film No.: 19803816
SIC: 2836 Biological Products, (No Diagnostic Substances)